Induction of ependymal, glial, and neuronal transactivation by intraventricular administration of the SGLT1 Na+-D-glucose cotransporter inhibitor phlorizin
Kp. Briski et Es. Marshall, Induction of ependymal, glial, and neuronal transactivation by intraventricular administration of the SGLT1 Na+-D-glucose cotransporter inhibitor phlorizin, NEUROCHEM R, 26(7), 2001, pp. 783-792
Reports that food intake is stimulated by intracerebroventricular (icv) adm
inistration of the SGLT1 Na+-D-glucose cotransport inhibitor, phlorizin, su
ggest that decreased central glucose uptake is a stimulus for compensatory
motor activity underlying restoration of energy imbalance. In order to iden
tify central cell populations that are functionally responsive to decreased
SGLT1 function in the brain, the present study utilized immunocytochemical
techniques to demonstrate cellular expression of the inducible activator p
rotein-1 transcription factor, Fos, following icv delivery of phlorizin. Gr
oups of adult male rats were treated with phlorizin at a dose of 10, 50, or
250 mug/animal, then sacrificed 2hr later by transcardial perfusion. Epend
ymal expression of immunoreactivity (-ir) was observed throughout most of t
he cerebroventricular system, except the medullary fourth ventricle, at eac
h dose examined. Higher doses of the transport inhibitor elicited immunosta
ining of periventricular glia, characterized by cytoplasmic glial fibrillar
y acidic protein-ir, underlying the lateral, third, and rostral fourth vent
ricles and cerebral aqueduct. These doses also resulted in the transcriptio
nal activation of neurons in discrete brain sites, including the. rostral m
edial preoptic area, median preoptic n., preoptic and hypothalamic perivent
ricular n., subfornical organ, thalamic medial habenular and paraventricula
r n., hypothalamic paraventricular, ventromedial, and arcuate n., and n. of
the solitary tract. These results show that nonexcitable cells located thr
oughout much of the central neuroaxis and discrete populations of neurons i
n the brain are genomically responsive to pharmacological inhibition of cen
tral SGLT1 function. Evidence for the functional responsiveness of these ce
ll types to manipulation of energy-dependent glucose transport suggests tha
t cellular uptake of this metabolic fuel may serve as an indicator of centr
al energy substrate availability, and that alterations in glucose uptake vi
a this specific mechanism may be the source of regulatory signals involved
in the maintenance of energy homeostasis.